• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

CytoArm Co.,Ltd.

Wednesday, June 05, 2024
Start-Up Stadium Session
Oncology
Company Description: CytoArm focuses on untreatable diseases through a next generation T cell therapy, Armed-T cell. We are led by experts in both business & medical area, with comprehensive experience in the development of novel T-cell therapies for clinical treatments. Our core technology, a cutting-edge virus-free T cell manufacturing platform, offers a single-step manufacturing process to obtain high purity (>90%) cancer-specific T cells in only one third of the time compared to current CAR-T cell therapy. The first Armed-T cell product, targeting the treatment of colorectal cancer with EGFR downstream gene mutations, is ready to initiate an clinical trial in 2024.

CytoArm Co.,Ltd.
Company Website: https://www.cytoarm.com/

Company HQ City

Nangang Dist., Taipei

Company HQ State

Taiwan

Company HQ Country

Taiwan

CEO/Top Company Official

Kuo-Hsiang Chuang
Primary Speaker
Kuo-Hsiang Chuang, PhD
Chief Executive Officer
CytoArm Co.,Ltd.
Back to Session List

white squarewhite

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS